 In 2008, he founded The Petkevich Group, a boutique advisory firm where he was Chairman and CEO from 1998 to 2005.In 2006, he co-founded along with Dennis McCoy, MD, BladeRock Capital, the General Partner of the V2MTM Life Sciences Fund.The Fund makes contrarian investments in undervalued public companies, which are developing medical breakthrough products that address large, unmet medical needs.